价格

therapeutics (inflammatory diseases )

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

TRICYCLIC JANUS KINASE 1 INHIBITORS, AND COMPOSITIONS AND METHODS THEREOF
EP 3856742 C0申请人: LYNK PHARMACEUTICALS CO LTD优先权: 2018
CN
EP
US
WO
12 件公开
Novel pyridazine derivatives and medicines containing the same as effective ingredients
US 2005267113 A1申请人: KOWA CO优先权: 1997
US
11 件公开
Variable region sequences of IL-31 monoclonal antibodies and methods of use
US 8466262 B2申请人: SIADAK ANTHONY W优先权: 2006
CN
US
10 件公开
Mouse titers after two immunizations with VLPs alone
US 7371572 B2申请人: US DEPT OF HEALTH OF HUMAN SER优先权: 2001
US
9 件公开
GENETICALLY MODIFIED PROBIOTICS FOR ORAL DELIVERY OF RENIN-ANGIOTENSIN RELATED THERAPEUTIC PROTEINS AND PEPTIDES
US 2019263878 A1申请人: UNIV FLORIDA优先权: 2016
US
WO
8 件公开
Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use
US 10723718 B2申请人: UNIV MICHIGAN REGENTS优先权: 2017
US
WO
7 件公开
SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF
- EP 4543888 A4
  申请人: UNIV ARIZONA优先权: 2022
  EP
  US
  WO
  6 件公开
- US 12528810 B2
  申请人: UNIV ARIZONA优先权: 2019
  US
High affinity antibodies against HMGB1 and methods of use thereof
- US 7585504 B2
  申请人: MEDIMMUNE LLC优先权: 2004
  CN
  US
  6 件公开
- US 7964706 B2
  申请人: MEDIMMUNE LLC优先权: 2006
  US
  3 件公开
- US 2011287023 A1
  申请人: WU HERREN优先权: 2011
  US
  2 件公开
SMALL MOLECULE INHIBITORS OF DYRK1/CLK AND USES THEREOF
- EP 3856186 A4
  申请人: UNIV ARIZONA优先权: 2018
  CN
  EP
  US
  WO
  5 件公开
- WO 2026096717 A1
  申请人: UNIV ARIZONA优先权: 2024
  WO
Modified proteases that inhibit complement activation
EP 2428218 A1申请人: CATALYST BIOSCIENCES INC优先权: 2006
EP
US
5 件公开

药物

therapeutics (inflammatory diseases )

专利

SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF

High affinity antibodies against HMGB1 and methods of use thereof

SMALL MOLECULE INHIBITORS OF DYRK1/CLK AND USES THEREOF